Advertisement

Topics

Prothena Corporation plc: Prothena Reports Fourth Quarter and Full Year 2017 Financial Results, and Provides Financial Guidance and R&D Update

16:16 EST 14 Feb 2018 | FinanzNachrichten

Net cash used in operating and investing activities was $39.9 million in the fourth quarter and $134.7 million for the full year 2017; quarter-end cash and restricted cash position of $421.7 milli...

Original Article: Prothena Corporation plc: Prothena Reports Fourth Quarter and Full Year 2017 Financial Results, and Provides Financial Guidance and R&D Update

NEXT ARTICLE

More From BioPortfolio on "Prothena Corporation plc: Prothena Reports Fourth Quarter and Full Year 2017 Financial Results, and Provides Financial Guidance and R&D Update"

Advertisement
Quick Search
Advertisement
Advertisement